Efficacy and safety of oral treprostinil monotherapy for the treatment of pulmonary arterial hypertension: A randomized, controlled trial

导出原文传递

翻译打印收藏纠错

作者： Jing,Z.-C. ^[1] ; Parikh,K. ^[2] ; Pulido,T. ^[3] ; Jerjes-Sanchez,C. ^[4] ; White,R.J. ^[5] ; Allen,R. ^[6] ; Torbicki,A. ^[7] ; Xu,K.-F. ^[8] ; Yehle,D. ^[9] ; Laliberte,K. ^[10] ; Arneson,C. ; Rubin,L.J.

作者单位： Shanghai Pulmonary Hospital, Tongji University School of Medicine, No. 507 Zhengmin Rd, Yangpu ^[1] UCSD Medical Center, San Diego, CA, United States ^[2] Medical Center of Postgraduate Education, ECZ, Otwock, Poland ^[3] Instituto Nacional de Cardiologia, Mexico City, Mexico ^[4] Unidad de Investigacion Clinica en Medicina, Monterrey, Mexico ^[5] United Therapeutics Corp, Research Triangle, Park, NC, United States ^[6] Care Institute of Medical Science, Ahmedabad, India ^[7] UC Davis Medical Center, Sacramento, CA, United States ^[8] Peking Union Medical College Hospital, Beijing, China ^[9] University of Rochester Medical Center, Rochester, NY, United States ^[10]

关键词 Exercise test prostacyclin analogue pulmonary arterial hypertension treprostinil

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交